Biomarker Conservation in Primary and Metastatic Epithelial Ovarian Cancer
Authors:
- Ainura S. KyshtoobayevaAKAinura S. Kyshtoobayeva
- Rita S. MehtaRMRita S. Mehta
- Ing-Ru YuIYIng-Ru Yu
- Robert A. BurgerRBRobert A. Burger
- Philip J. DiSaiaPDPhilip J. DiSaia
- John P. FruehaufJFJohn P. Fruehauf
Open Access
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 78 (2) , 130-136
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1997
- p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumoursEuropean Journal of Cancer, 1996
- Detection of Cellular Heterogeneity by DNA Ploidy, 17 Chromosome, and p53 Gene in Primary Carcinoma and Metastasis in a Case of Ovarian CancerInternational Journal of Gynecological Pathology, 1996
- The molecular basis of ovarian cancerCancer, 1995
- Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergenceBritish Journal of Cancer, 1995
- Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinomaCancer, 1994
- Ovarian carcinoma heterogeneity as demonstrated by DNA ploidyCancer, 1993
- Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome InactivationJNCI: Journal of the National Cancer Institute, 1992
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976
- X‐CHROMOSOME INACTIVATION AND DEVELOPMENTAL PATTERNS IN MAMMALSBiological Reviews, 1972